0.5 mg Ebunat Eribulin mesylate Solution for Injection - NBG Pharmaceuticals
+91 94054 76170 nbgcorporation@gmail.com Mon-Fri: 9:00 AM - 6:00 PM
ANTI - CANCER INJECTION

0.5 mg Ebunat Eribulin mesylate Solution for Injection

4.5 (24 reviews)
Price on Request
Treatment Metastatic Breast Cancer
Dosage Form Dosage Form: Solution for Injection
Route Of Administration intravenous (IV) injection or infusion.
Packaging Size 2 ml
Packaging Type Vial
Brand Ebunat
Composition Eribulin Mesylate Injection
Strength 0.5 mg/ml
Country of Origin Made in India
Form Injection
Minimum order quantity: 50 Vial

Ebunat (0.5 mg/ml Eribulin mesylate) is a chemotherapy injection used to treat adults with advanced or metastatic breast cancer and liposarcoma. It is administered exclusively by healthcare professionals via intravenous (IV) infusion, typically on Days 1 and 8 of a 21-day cycle.

liketo,usa.uk.china.southkorea.russia.japan.singapore
Category: ANTI - CANCER INJECTION
SKU: EP-000045
Enquire About This Product
Loading...